Andre Goy

Join us tonight for a Day 2 of the CME Accredited ASH Update. To register please go to: https://t.co/iK1e8MMEVF https://t.co/5yhZeb7ktm

RT @MarkSpartaFACHE: March 9 will forever be known as #COVID19 Heroes Day in #NJ https://t.co/xMAlpbnNy2$

RT @nyknicks: The Knicks and Tackle Kids Cancer Foundation have teamed up again to fight Childhood Cancer. For every Knicks block this se…

Join Us Tomorrow for Day 2 of the CME Accredited ASH Update. To register please go to https://t.co/kkyFn72fr1 https://t.co/iFWwqlFuQR

Tune in NOW to cover the current standards for R-CHOP therapy for lymphoma. Join us for our Mentors in Medicine Series on Applied Precision Medicine webcast, “Focus on R-CHOP in Lymphoma”. Register here: https://t.co/zRYBipx9OK

In 1 hour, you can join the Mentors in Medicine Series webcast to hear a panel of renowned experts discuss the management of adverse events associated with R-CHOP therapy. Join at: https://t.co/EIkdZtjrRh

Our Mentors in Medicine webcast is live NOW. Tune in to gain expert insights on the current standards for triple-negative breast cancer. Join us now at: https://t.co/2qxpgydhWo

Join Physicians Education Resource®, LLC (PER®) for the 2nd Mentors in Medicine program "Focus on Triple-Negative Breast Cancer" webcast tonight. Tune in at 7:30 PM EST to learn how to incorporate biomarker testing into diagnosis and therapy selection. https://t.co/2qxpgyuSNW

Launching our first MENTORS IN MEDICINE w / JOHN THEURER CANCER DEEP DIVING ON PICKING BEST OPTION FOR EVERY PATIENT - AMAZING INSIGHTS FROM Drs ANDERSON LONIAL ALSINA AND BIRAN. PRECISE MEDICINE IN MYELOMA. Thank you for all you DO!

#DYK age-related changes in endothelial cells play a role in the progression of blood cancers? I had a virtual sit-down with my colleague, Dr. Butler, whose team is exploring how aging endothelial cells lead to blood stem cell function disruption: https://t.co/gRJVHSkXj8 https://t.co/dMAO0z9QMk

I recently spoke to my colleague, @JMBStemCell, whose team is working on unraveling the mechanisms by which aging endothelial cells lead to the disturbance of blood stem cell function, and the progression of certain blood #cancers. Learn more: https://t.co/rnmSR2Evib https://t.co/3SZ2rTlfx0

I virtually sat down with Dr. Rena Feinman, who is working with her team to advance the understanding of the #microbiome and its role in cancer. Learn more about how a better understanding of the microbiome can reshape our approach to cancer treatment: https://t.co/08bWKZlMC5 https://t.co/EhoWWA30jr

#DYK there is growing evidence that the #microbiome plays an important role in many aspects of human cancers – including progression and treatment response? I had a virtual sit-down with my colleague, Dr. Rena Feinman, to learn more: https://t.co/08bWKZlMC5 https://t.co/zv5RvKel7k

Join me on tomorrow, September 26 as I lead @gotoPER's "2nd Annual Precision Medicine Symposium: An Illustrated Tumor Board" virtual, interactive conference to hear the latest clinical insights in major solid and liquid tumors. Register at: https://t.co/e1zVr7rbmG

I had the opportunity to virtually sit-down with Dr. Benjamin Tycko, my colleague and co-author on a new study that can help unlock the potential of #epigenetics. Learn more about how these exciting findings can impact cancer treatment: https://t.co/NrUV50zzId https://t.co/Xg19LAB76r

Our team at @JTCancerCenter recently participated in a study delving into the fairly new field of #epigenetics. The exciting findings revealed signposts in DNA that may pinpoint risks for cancer and other diseases. Learn more: https://t.co/NrUV50zzId https://t.co/gdHSDe9Y49

Great News: The FDA has approved the CAR T-cell therapy brexucabtagene autoleucel (Tecartus; formerly KTE-X19) as a treatment for adult patients with relapsed/refractory mantle cell #lymphoma.